Expert Narukawa Backs JPMA Pitch on Value-Based Pricing, but Disputes Blanket Price Maintenance for Patented Meds

Mamoru Narukawa, Professor, Kitasato University Graduate School of Pharmaceutical Sciences Japan should revamp its drug pricing system into one that ensures returns for R&D investments if the country is to eliminate the drug lag, Mamoru Narukawa, a member of a...read more